Member Info for inanaco

we saw £10 ... it reinforced £7.88

I have no issues supporting £8 or £10 ... plenty of comparisons .. not least Keytruda sales ...

calling Ruck in ............

I have been promoting his £10 valuation as well ........... an excellent post

i am so accommodating of alternative views

Bunsie i have been told to be more humble to others ... gentle , less abrasive, accommodating

i highlighted ... and have promoted ever since ....

"""So you may also want to question the market why it values the company at this ludicrous level""

great posts that support Mhighbar ... Micheal should feel proud ...

"""So you may also want to question the market why it values the company at this ludicrous level""

yep ... another great post ...

its significant if you look back over history as these options granted back in 2010 approx when the sp was about 6p when it floated on Aim prior it was on the plus market at 60p approx but they did a share division by 10 when they floated.. they linked to a sale of scancell .. which subsequently got changed to a SP level as the aims of the company changed

spot on Chester .....

so best to consider how you can best take advantage of

"""So you may also want to question the market why it values the company at this ludicrous level""

rather than fighting it .....

ATB

pointing out the BOD do have an incentive towards the SP >>>>> so why would they deliberately evade communication ? or not make and effort to communicate .. leaving shareholders unloved ... ?

just maybe some are over "over expecting" information ....

anyway time for Cricket ..........

suns out

this is from memory Bermuda will have the numbers ........ the vesting of those shares requires an SP of 22p ... min

interesting that David Evans used that number .... 22p

Are you going to kick off the “ludicrously cheap” discussion?

does it need a title ?

Richard and Lindy ..... had an enormous incentive to raise the Bar of the SP ... ie 7,000,000 share options at 4.5p
this month .. i am sure Bermuda has the dates

it works both ways ....

"""So you may also want to question the market why it values the company at this ludicrous level""

The Options have an exercise price of 8.15 pence each and will vest twelve months from the date of Grant.

Diggles sold some of his trading Pot ..........

1,500,000 Ordinary Shares

8 pence per Ordinary Share

..................... you cannot say that Scancell directors are "profiteering" .......... with an Option set at 8.15p

well Ruck its my opinion it is correct .............. and trying to divert blame onto Scancell for the SP is wrong ... for a start they have no control over it ...

Directors have given up salary in exchange for a higher share price option which They have to pay for .... 8p i think

"""So you may also want to question the market why it values the company at this ludicrous level""

for that you have to look at yourselves ... as each of us make up the market ...

I am quite happy ... ............... after all if You consider Mhighbars intervention helpful ... then i will pick up the only point of value which was this .....

"""So you may also want to question the market why it values the company at this ludicrous level""

of which my reply was

and how do we do that exactly ??

ATB ...............

... so you raved about the post .......... now you are distancing ... ?

really Ruck ...

so this was not posted .....

""""The aim of my post was to see to what extent other investors had similar thoughts about issues related to the overall management style in order to bring them up at the AGM in a concerted way. """" M.highbar"

another figment of my imagination .... suppose that was like yours over the £10 share ...

take the BioNtech ...

Lindy has confirmed ........... "we have a working CD4 t cell that has been transfected"

they publish ......... Avidmab 2811

this Mab ... selectively picks out of patients blood the most efficacious and strongest CD4 t cell to transfect with a moditope TCR

tell me what do you need to Know ............. ?

Scancell holds Two patents ..... over the possible Commercial aspects of the collaboration with BioNtech and judging by the response rates of BioNtech/Roche deal ... maybe Scancell is streets ahead over vaccine development as well, thus its input into this collaboration maybe far higher than we first thought ... that is called "Value Added"

£25m market Cap v £150b combined ...

lots going on .